NCT05974904View on ClinicalTrials.gov

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

RecruitingOBSERVATIONAL
Enrollment

7,000

Participants

Timeline

Start Date

July 18, 2023

Primary Completion Date

December 28, 2026

Study Completion Date

December 28, 2026

Conditions
Metabolic Dysfunction-associated Fatty Liver DiseaseHepatic SteatosisLiver Fibrosis
Interventions
OTHER

high-sensitivity C-reactive protein to albumin ratio

High-sensitivity C-reactive protein to albumin ratio is an inflammatory indicator which can make a determination of disease severity.

Trial Locations (1)

400000

RECRUITING

The Second Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
lead

Chongqing Medical University

OTHER